We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 29

European Commission publishes guidelines on use of food-related health claims

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • January 28 2013

On 25 January 2013, the European Commission's new guidelines regarding the use of food-related health claims ("Guidelines") were published in the

EU pharma sector report pushes regulatory reform

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • July 8 2009

Earlier today, the European Commissioner for Competition, Neelie Kroes, presented the Final Report on the Commission’s Pharmaceutical Sector Inquiry

EU and ISO deliberating on nanotechnology labeling guidance

  • Sidley Austin LLP
  • -
  • European Union, Global
  • -
  • November 8 2010

The European Committee For Standardization (CEN) and the International Organization For Standardization (ISO) have jointly distributed for ballot and comment a document titled "Guidance on the labeling of manufactured nano-objects and products containing manufactured nano-objects," ISOTS 13830:2010

European Commission proposes controversial definition of nanomaterials

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • November 8 2010

On October 25, the European Commission (EC) proposed a definition of "nanomaterial" that would be used as a model by EU regulatory agencies

EU court pharmaceutical ruling may embolden Commission

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • July 15 2010

In a long-awaited judgment handed down on July 1, 2010, the EU's General Court has upheld a landmark 2005 European Commission ("Commission") decision finding that AstraZeneca had abused a dominant position in relation to Losec, its blockbuster antacid

European Commission allows submission of new data in support of probiotic health claims

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • June 20 2011

The European Commission has opened a four-month window, starting on June 1 and closing on September 30, 2011, during which stakeholders can submit new data to Member States in support of certain probiotic health claims rejected by the European Food Safety Authority

European Medicines Agency publishes new electronic submission format of information on medicines

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • August 22 2011

The European Medicines Agency (“EMA”) has published the new electronic format in which pharmaceutical companies will need to submit information on medicinal products for human use authorized or registered in the European Union

European Commission proposes overhaul of dietetic foods regime

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • August 1 2011

The European Commission adopted a proposal for a Regulation on Food Intended for Infants and Young Children and on Food for Special Medical Purposes (the “Proposed Regulation”) on June 20, 2011

European Union adopts falsified medicines directive

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • June 7 2011

On May 27, 2011 the Council of the European Union (Council) adopted a directive aimed at preventing falsified medicines from entering into the legal supply chain

European Commission publishes new guidance on clinical trials safety reporting

  • Sidley Austin LLP
  • -
  • European Union
  • -
  • July 25 2011

The European Commission’s new detailed guidance on the collection, verification and presentation of adverse eventreaction reports arising from clinical trials on medicinal products for human use (“CT-3”) was published on 11 June 2011 in the European Union’s Official Journal